Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Process Hepatitis B Vaccine in Healthy Adults >50
NCT00440531Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2006
- Primary completion
- Nov 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Merck & Co.. Started Nov 2006; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00440531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440531.